Evaluation of HCPTd1, d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

248

HTML

1285

Tables (1-2)

175

Sum=1708

Sep 7, 2005 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 7, 2005; 11(33): 5221-5225
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5221

Table 2 Hepatic cancerous marker alterations before and after treatment

P: positive; N: negative; D: decrease; I: increase.

Citation: Yu ZJ, Yu JW, Cai W, Yuan HX, Li XY, Yuan Y, Chen JP, Wu XY, Yao DF. Evaluation of HCPTd₁, d₁₄-double passaged intervening chemotherapy protocol for hepatocellular carcinoma. World J Gastroenterol 2005; 11(33): 5221-5225
URL: https://www.wjgnet.com/1007-9327/full/v11/i33/5221.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i33.5221